Global Radioimmunotherapy Competitive Landscape Professional Research Report 2026

According to DIResearch＇s in-depth investigation and research, the global Radioimmunotherapy market size will reach 2,903.82 Million USD in 2025 and is projected to reach 7,528.90 Million USD by 2032, with a CAGR of 14.58% (2025-2032). Notably, the China Radioimmunotherapy market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.

Research Summary

Radioimmunotherapy (RIT) is a specialized cancer treatment that harnesses the specificity of monoclonal antibodies and the cytotoxic power of radiation. It involves attaching radioactive isotopes to monoclonal antibodies, which are proteins designed to selectively target antigens found on cancer cells. Once administered into the patient＇s bloodstream, these antibodies seek out and bind to the cancer cells, delivering radiation directly to the tumor sites. The emitted radiation damages the cancer cells＇ DNA, leading to their destruction or death. Radioimmunotherapy offers the advantage of precise targeting, minimizing harm to surrounding healthy tissues compared to traditional radiation therapy and chemotherapy. It is particularly effective against certain types of blood cancers like lymphoma and leukemia, and ongoing research aims to expand its application to other types of solid tumors, offering promising therapeutic options for cancer patients.

The major global suppliers of Radioimmunotherapy include Bayer, Novartis, Lantheus, Aurobindo Pharma, Mundipharma, China Isotope & Radiation, Curium Pharmaceuticals, Gilead Sciences, Clarity Pharmaceuticals, Curasight, Nordic Nanovector, Philogen, RadioMedix, Telix Pharmaceuticals, Orano Med, Actinium Pharmaceuticals, Y-mAbs Therapeutics, Fusion Pharmaceuticals, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Radioimmunotherapy. Focus on analysing the market share, product portfolio, prices, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Radioimmunotherapy market. The report data covers historical data from 2021 to 2025, based year in 2026 and forecast data from 2027 to 2033.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Radioimmunotherapy market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Radioimmunotherapy industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.  

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Suppliers of Radioimmunotherapy Include:

Bayer

Novartis

Lantheus

Aurobindo Pharma

Mundipharma

China Isotope & Radiation

Curium Pharmaceuticals

Gilead Sciences

Clarity Pharmaceuticals

Curasight

Nordic Nanovector

Philogen

RadioMedix

Telix Pharmaceuticals

Orano Med

Actinium Pharmaceuticals

Y-mAbs Therapeutics

Fusion Pharmaceuticals

Radioimmunotherapy Product Segment Include:

Beta-emitting

Targeted Alpha Therapy

Radioimmunotherapy Product Application Include:

Solid Tumor

Non Hodgkin Lymphoma

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Radioimmunotherapy Industry PESTEL Analysis

Chapter 3: Global Radioimmunotherapy Industry Porter’s Five Forces Analysis

Chapter 4: Global Radioimmunotherapy Major Regional Market Size and Forecast Analysis

Chapter 5: Global Radioimmunotherapy Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Passenger Radioimmunotherapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Radioimmunotherapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Radioimmunotherapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Radioimmunotherapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Radioimmunotherapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Radioimmunotherapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Radioimmunotherapy Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table 1： Global Radioimmunotherapy Market Size Growth Rate by Type, 2025 VS 2026 VS 2033 (US$ Million)

Table 2： Global Radioimmunotherapy Market Size Growth Rate by Application, 2025 VS 2026 VS 2033 (US$ Million)

Table 3： Radioimmunotherapy Industry Development Status

Table 4： Radioimmunotherapy Industry Development Trends

Table 5： Global Radioimmunotherapy Market Size by Region in US$ Million: 2025 VS 2026 VS 2033

Table 6： Global Radioimmunotherapy Revenue by Region (2021-2026) & (US$ Million)

Table 7： Global Radioimmunotherapy Revenue Market Share by Region (2021-2026)

Table 8： Global Radioimmunotherapy Revenue Forecast by Region (2027-2033) & (US$ Million)

Table 9： Global Radioimmunotherapy Revenue Market Share Forecast by Region (2027-2033)

Table 10： Global Radioimmunotherapy Revenue Analysis by Type (2021-2026) & (US$ Million)

Table 11： Global Radioimmunotherapy Revenue Analysis Forecast by Type (2027-2033) & (US$ Million)

Table 12： Global Radioimmunotherapy Revenue Analysis by Application (2021-2026) & (US$ Million)

Table 13： Global Radioimmunotherapy Revenue Analysis Forecast by Application (2027-2033) & (US$ Million)

Table 14： Key Radioimmunotherapy Players in North America

Table 15： North America Radioimmunotherapy Revenue by Type (2021-2026) & (US$ Million)

Table 16： North America Radioimmunotherapy Revenue by Type (2027-2033) & (US$ Million)

Table 17： North America Radioimmunotherapy Revenue by Application (2021-2026) & (US$ Million)

Table 18： North America Radioimmunotherapy Revenue by Application (2027-2033) & (US$ Million)

Table 19： North America Radioimmunotherapy Revenue Market Size by Country (2021-2026) & (US$ Million)

Table 20： North America Radioimmunotherapy Revenue Market Size by Country (2027-2033) & (US$ Million)

Table 21： Key Radioimmunotherapy Players in Europe

Table 22： Europe Radioimmunotherapy Revenue by Type (2021-2026) & (US$ Million)

Table 23： Europe Radioimmunotherapy Revenue by Type (2027-2033) & (US$ Million)

Table 24： Europe Radioimmunotherapy Revenue by Application (2021-2026) & (US$ Million)

Table 25： Europe Radioimmunotherapy Revenue by Application (2027-2033) & (US$ Million)

Table 26： Europe Radioimmunotherapy Revenue Market Size by Country (2021-2026) & (US$ Million)

Table 27： Europe Radioimmunotherapy Revenue Market Size by Country (2027-2033) & (US$ Million)

Table 28： Key Radioimmunotherapy Players in China

Table 29： China Radioimmunotherapy Revenue by Type (2021-2026) & (US$ Million)

Table 30： China Radioimmunotherapy Revenue by Type (2027-2033) & (US$ Million)

Table 31： China Radioimmunotherapy Revenue by Application (2021-2026) & (US$ Million)

Table 32： China Radioimmunotherapy Revenue by Application (2027-2033) & (US$ Million)

Table 33： Key Radioimmunotherapy Players in APAC (excl. China)

Table 34： APAC (excl. China) Radioimmunotherapy Revenue by Type (2021-2026) & (US$ Million)

Table 35： APAC (excl. China) Radioimmunotherapy Revenue by Type (2027-2033) & (US$ Million)

Table 36： APAC (excl. China) Radioimmunotherapy Revenue by Application (2021-2026) & (US$ Million)

Table 37： APAC (excl. China) Radioimmunotherapy Revenue by Application (2027-2033) & (US$ Million)

Table 38： APAC (excl. China) Radioimmunotherapy Revenue Market Size by Country (2021-2026) & (US$ Million)

Table 39： APAC (excl. China) Radioimmunotherapy Revenue Market Size by Country (2027-2033) & (US$ Million)

Table 40： Key Radioimmunotherapy Players in Latin America

Table 41： Latin America Radioimmunotherapy Revenue by Type (2021-2026) & (US$ Million)

Table 42： Latin America Radioimmunotherapy Revenue by Type (2027-2033) & (US$ Million)

Table 43： Latin America Radioimmunotherapy Revenue by Application (2021-2026) & (US$ Million)

Table 44： Latin America Radioimmunotherapy Revenue by Application (2027-2033) & (US$ Million)

Table 45： Latin America Radioimmunotherapy Revenue Market Size by Country (2021-2026) & (US$ Million)

Table 46： Latin America Radioimmunotherapy Revenue Market Size by Country (2027-2033) & (US$ Million)

Table 47： Key Radioimmunotherapy Players in Middle East & Africa

Table 48： Middle East & Africa Radioimmunotherapy Revenue by Type (2021-2026) & (US$ Million)

Table 49： Middle East & Africa Radioimmunotherapy Revenue by Type (2027-2033) & (US$ Million)

Table 50： Middle East & Africa Radioimmunotherapy Revenue by Application (2021-2026) & (US$ Million)

Table 51： Middle East & Africa Radioimmunotherapy Revenue by Application (2027-2033) & (US$ Million)

Table 52： Middle East & Africa Radioimmunotherapy Revenue Market Size by Country (2021-2026) & (US$ Million)

Table 53： Middle East & Africa Radioimmunotherapy Revenue Market Size by Country (2027-2033) & (US$ Million)

Table 54： Global Radioimmunotherapy Market Revenue by Key Suppliers (2021-2026) & (US$ Million)

Table 55： Global Radioimmunotherapy Revenue Market Share by Key Suppliers (2021-2026)

Table 56： Global Key Suppliers Headquarter Location and Key Area Sales

Table 57： Market Mergers & Acquisitions, Expansion

Table 58： Bayer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 59： Bayer Radioimmunotherapy Product Portfolio

Table 60： Bayer Radioimmunotherapy Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 61： Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 62： Novartis Radioimmunotherapy Product Portfolio

Table 63： Novartis Radioimmunotherapy Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 64： Lantheus Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 65： Lantheus Radioimmunotherapy Product Portfolio

Table 66： Lantheus Radioimmunotherapy Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 67： Aurobindo Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 68： Aurobindo Pharma Radioimmunotherapy Product Portfolio

Table 69： Aurobindo Pharma Radioimmunotherapy Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 70： Mundipharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 71： Mundipharma Radioimmunotherapy Product Portfolio

Table 72： Mundipharma Radioimmunotherapy Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 73： China Isotope & Radiation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 74： China Isotope & Radiation Radioimmunotherapy Product Portfolio

Table 75： China Isotope & Radiation Radioimmunotherapy Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 76： Curium Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 77： Curium Pharmaceuticals Radioimmunotherapy Product Portfolio

Table 78： Curium Pharmaceuticals Radioimmunotherapy Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 79： Gilead Sciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 80： Gilead Sciences Radioimmunotherapy Product Portfolio

Table 81： Gilead Sciences Radioimmunotherapy Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 82： Clarity Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 83： Clarity Pharmaceuticals Radioimmunotherapy Product Portfolio

Table 84： Clarity Pharmaceuticals Radioimmunotherapy Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 85： Curasight Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 86： Curasight Radioimmunotherapy Product Portfolio

Table 87： Curasight Radioimmunotherapy Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 88： Nordic Nanovector Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 89： Nordic Nanovector Radioimmunotherapy Product Portfolio

Table 90： Nordic Nanovector Radioimmunotherapy Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 91： Philogen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 92： Philogen Radioimmunotherapy Product Portfolio

Table 93： Philogen Radioimmunotherapy Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 94： RadioMedix Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 95： RadioMedix Radioimmunotherapy Product Portfolio

Table 96： RadioMedix Radioimmunotherapy Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 97： Telix Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 98： Telix Pharmaceuticals Radioimmunotherapy Product Portfolio

Table 99： Telix Pharmaceuticals Radioimmunotherapy Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 100： Orano Med Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 101： Orano Med Radioimmunotherapy Product Portfolio

Table 102： Orano Med Radioimmunotherapy Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 103： Actinium Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 104： Actinium Pharmaceuticals Radioimmunotherapy Product Portfolio

Table 105： Actinium Pharmaceuticals Radioimmunotherapy Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 106： Y-mAbs Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 107： Y-mAbs Therapeutics Radioimmunotherapy Product Portfolio

Table 108： Y-mAbs Therapeutics Radioimmunotherapy Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 109： Fusion Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 110： Fusion Pharmaceuticals Radioimmunotherapy Product Portfolio

Table 111： Fusion Pharmaceuticals Radioimmunotherapy Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 112： Radioimmunotherapy Typical Customer List

Table 113： Radioimmunotherapy Distributors List

Figure 1： Radioimmunotherapy Product Pictures

Figure 2： Beta-emitting Picture Scope

Figure 3： Targeted Alpha Therapy Picture Scope

Figure 4： Solid Tumor Picture Scope

Figure 5： Non Hodgkin Lymphoma Picture Scope

Figure 6： Global Radioimmunotherapy Market Size Analysis: 2025 VS 2026 VS 2033 (US$ Million)

Figure 7： Global Radioimmunotherapy Market Revenue and Growth Rate Analysis: (2021-2033) & (US$ Million)

Figure 8： Global Radioimmunotherapy Market Size by Region (2021-2033) & (US$ Million)

Figure 9： Global Radioimmunotherapy Market Share Scenario by Region in Percentage: 2026 Versus 2033

Figure 10： North America Radioimmunotherapy Market Size and Growth Rate (2021-2033) & (US$ Million)

Figure 11： North America Radioimmunotherapy Market Share by Players in 2025

Figure 12： North America Radioimmunotherapy Revenue Market Share by Type (2021-2033)

Figure 13： North America Radioimmunotherapy Revenue Market Share by Application (2021-2033)

Figure 14： US Radioimmunotherapy Revenue (2021-2033) & (US$ Million)

Figure 15： Canada Radioimmunotherapy Revenue (2021-2033) & (US$ Million)

Figure 16： Europe Radioimmunotherapy Market Size and Growth Rate (2021-2033) & (US$ Million)

Figure 17： Europe Radioimmunotherapy Market Share by Players in 2025

Figure 18： Europe Radioimmunotherapy Revenue Market Share by Type (2021-2033)

Figure 19： Europe Radioimmunotherapy Revenue Market Share by Application (2021-2033)

Figure 20： Germany Radioimmunotherapy Revenue (2021-2033) & (US$ Million)

Figure 21： France Radioimmunotherapy Revenue (2021-2033) & (US$ Million)

Figure 22： United Kingdom Radioimmunotherapy Revenue (2021-2033) & (US$ Million)

Figure 23： Italy Radioimmunotherapy Revenue (2021-2033) & (US$ Million)

Figure 24： Spain Radioimmunotherapy Revenue (2021-2033) & (US$ Million)

Figure 25： Benelux Radioimmunotherapy Revenue (2021-2033) & (US$ Million)

Figure 26： China Radioimmunotherapy Market Size and Growth Rate (2021-2033) & (US$ Million)

Figure 27： China Radioimmunotherapy Market Share by Players in 2025

Figure 28： China Radioimmunotherapy Revenue Market Share by Type (2021-2033)

Figure 29： China Radioimmunotherapy Revenue Market Share by Application (2021-2033)

Figure 30： APAC (excl. China) Radioimmunotherapy Market Size and Growth Rate (2021-2033) & (US$ Million)

Figure 31： APAC (excl. China) Radioimmunotherapy Market Share by Players in 2025

Figure 32： APAC (excl. China) Radioimmunotherapy Revenue Market Share by Type (2021-2033)

Figure 33： APAC (excl. China) Radioimmunotherapy Revenue Market Share by Application (2021-2033)

Figure 34： Japan Radioimmunotherapy Revenue (2021-2033) & (US$ Million)

Figure 35： South Korea Radioimmunotherapy Revenue (2021-2033) & (US$ Million)

Figure 36： India Radioimmunotherapy Revenue (2021-2033) & (US$ Million)

Figure 37： Australia Radioimmunotherapy Revenue (2021-2033) & (US$ Million)

Figure 38： Southeast Asia Radioimmunotherapy Revenue (2021-2033) & (US$ Million)

Figure 39： Latin America Radioimmunotherapy Market Size and Growth Rate (2021-2033) & (US$ Million)

Figure 40： Latin America Radioimmunotherapy Market Share by Players in 2025

Figure 41： Latin America Radioimmunotherapy Revenue Market Share by Type (2021-2033)

Figure 42： Latin America Radioimmunotherapy Revenue Market Share by Application (2021-2033)

Figure 43： Mexico Radioimmunotherapy Revenue (2021-2033) & (US$ Million)

Figure 44： Brazil Radioimmunotherapy Revenue (2021-2033) & (US$ Million)

Figure 45： Middle East & Africa Radioimmunotherapy Market Size and Growth Rate (2021-2033) & (US$ Million)

Figure 46： Middle East & Africa Radioimmunotherapy Market Share by Players in 2025

Figure 47： Middle East & Africa Radioimmunotherapy Revenue Market Share by Type (2021-2033)

Figure 48： Middle East & Africa Radioimmunotherapy Revenue Market Share by Application (2021-2033)

Figure 49： Saudi Arabia Radioimmunotherapy Revenue (2021-2033) & (US$ Million)

Figure 50： South Africa Radioimmunotherapy Revenue (2021-2033) & (US$ Million)

Figure 51： Global Radioimmunotherapy Revenue Market Share by Key Suppliers in 2025

Figure 52： Global Radioimmunotherapy Industry Competition Landscape

Figure 53： Radioimmunotherapy Industry Chain Analysis

Figure 54： Bottom-Up and Top-Down Research Methods

Figure 55： Key Interview Objectives

Figure 56： Data Cross Validation